# A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)

> **NCT05044533** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 50 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05044533
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-31
- **Primary completion:** 2022-03-09
- **Final completion:** 2022-03-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044533, "A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05044533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*